(Q40046671)

16 September 2017

title

A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses (English)

1 reference

16 September 2017

Salmonella Typhi

1 reference

Sayan Das

1

1 reference

16 September 2017

Rimi Chowdhury

series ordinal

2

1 reference

16 September 2017

Shubhamoy Ghosh

series ordinal

3

1 reference

16 September 2017

Santasabuj Das

series ordinal

4

1 reference

16 September 2017

language of work or name

English

0 references

publication date

21 July 2017

1 reference

16 September 2017

1 reference

16 September 2017

volume

35

1 reference

16 September 2017

issue

35 Pt B

1 reference

16 September 2017

page(s)

4523-4531

1 reference

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Vaccines against typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Development of Vi conjugate - a new generation of typhoid vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Multiplex PCR for differential diagnosis of emerging typhoidal pathogens directly from blood samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Homeostatic T cell proliferation in a T cell-dendritic cell coculture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Identification of Protective Antigens for Vaccination against Systemic Salmonellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Typhoid fever: pathogenesis and immunologic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Host-Salmonella interaction: human trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Antibodies and protection against invasive salmonella disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Protective host immune responses to Salmonella infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Development of acquired immunity to Salmonella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Oxygen-dependent anti-Salmonella activity of macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Macrophage cytokines: involvement in immunity and infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Patterns of proinflammatory cytokines and inhibitors during typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Long term persistence of inflammation in children vaccinated with Salmonella conjugate vaccine is associated with augmented Th9-Th17 cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Immunity to intracellular Salmonella depends on surface-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

An AIL family protein promotes type three secretion system-1-independent invasion and pathogenesis of Salmonella enterica serovar Typhi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Maintenance of serological memory by polyclonal activation of human memory B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

A mouse model for the human pathogen Salmonella typhi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

Infectious diseases in humanized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.035

10.1016/J.VACCINE.2017.07.035

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference